|
|
Dade Behring Holdings (DADE)This is an EDITABLE stock research wiki. You can contribute by clicking on the EDIT PAGE link above or on the page icons that appear when you roll over one of the category subtitles below. From 1Table of contents
Company Information:Company Address: 1717 Deerfield Road Deerfield, IL 60015
Company’s Web Address: http://www.dadebehring.com/
Industry Sector:
Fiscal Year: Dividend:
Note: this section is not editable.
Please click here to report any inaccuracies.
Company Overview:Note: this section is not editable.
Dade Behring Holdings, Inc. (DADE) is a manufacturer and distributor of in vitro diagnostics (IVD) products and services for clinical laboratories. Dade Behring's products and services comprise reagents and consumables, medical diagnostic instruments, and maintenance services. These are categorized into four business segments. The chemistry diagnostics business (66% of 2006 revenue) is engaged in routine chemistry/immunochemistry, cardiac, plasma proteins, and drugs of abuse testing, as well as therapeutic drug monitoring. The company has a routine chemistry/immunochemistry instrument platform called Dimension. The hemostasis business (18%) provides tests to measure a patient's ability to form and dissolve blood clots. The microbiology diagnostics business (10%) manufactures manual and automated Identification/Antibiotic Susceptibility Testing (ID/AST) products. Microbiology diagnostics products are available under the MicroScan trade name. The infectious disease diagnostic business (5%) is engaged in bacteriology, parasitology, and virology testing, including HIV and hepatitis testing. In addition to diagnoses of diseases, these tests are used for screening, in order to ensure a safe blood supply. The remaining 1% of revenue comes from other mature products that are no longer part of the company's core business.
Valuation:Enter Valuation Analysis and Valuation Ratios Here
Tags:
none
The opinions and views expressed in this document do not necessarily reflect the views or opinions of InvestingMinds. InvestingMinds did not prepare and does not endorse such content. Please note that it is intended for general circulation only and the recommendations contained herein do not take into account the specific investment objectives, financial situation or particular needs of any particular person. This document is for information purposes only and it should not be regarded as an offer to sell or as a solicitation of an offer to buy securities or other instruments. No part of this document may be reproduced in any manner without the written permission of InvestingMinds.
|
||||||||||||||||||||||||
|
|